Quick Answer
DEXCOM INC reported Revenue From Contract With Customer Excluding Assessed Tax of $4.66 billion for the year ending 2025.
- DEXCOM INC showed an increase of +15.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $142.30 million | Q2 2017: $170.60 million | Q3 2017: $184.60 million | Q4 2017: $221.00 million | Q1 2018: $184.40 million | Q2 2018: $242.50 million | Q3 2018: $266.70 million | Q4 2018: $338.00 million | Q1 2019: $280.50 million | Q2 2019: $336.40 million | Q3 2019: $396.30 million | Q4 2019: $462.80 million | Q1 2020: $405.10 million | Q2 2020: $451.80 million | Q3 2020: $500.90 million | Q1 2021: $505.00 million | Q2 2021: $595.10 million | Q3 2021: $650.20 million | Q1 2022: $628.80 million | Q2 2022: $696.20 million | Q3 2022: $769.60 million | Q1 2023: $741.50 million | Q2 2023: $871.30 million | Q3 2023: $975.00 million | Q1 2024: $921.00 million | Q2 2024: $1.00 billion | Q3 2024: $994.20 million | Q1 2025: $1.04 billion | Q2 2025: $1.16 billion | Q3 2025: $1.21 billion.
- Over the full 10 years of available data (2016 to 2025), DEXCOM INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 713.2%.
- Historical annual values: Fiscal year 2025: $4.66 billion | Fiscal year 2024: $4.03 billion | Fiscal year 2023: $3.62 billion | Fiscal year 2022: $2.91 billion | Fiscal year 2021: $2.45 billion | Fiscal year 2020: $1.93 billion | Fiscal year 2019: $1.48 billion | Fiscal year 2018: $1.03 billion | Fiscal year 2017: $718.50 million | Fiscal year 2016: $573.30 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: